Corrigendum to “What type 1 diabetes endotype is most suitable for anti-CD3 antibodies prevention trials?” [JDC, volume 39, issue 10, October 2025, 109132]

Journal of Diabetes and its Complications 2026

View at publisher

Authors: Maria Aurora Roma-Wilson, Paolo Pozzilli

DOI: 10.1016/j.jdiacomp.2025.109229

Cited by: 0

Fields of Study & Subjects

Diabetes and associated disorders Diabetes Management and Research T-cell and B-cell Immunology